Collectively, these findings conclusively demonstrate that IRF5 M1‐exos possess inhibitory effects on lung cancer cell survival and proliferation while attenuating cellular migration and invasion capabilities, thereby impeding tumorigenesis. Here, IRF5 is linked to lung cancer.